Tonsillectomy
Transcription
Tonsillectomy
Tonsillectomy – Who and Why? Janet A Wilson BAPO 2011 MacKee 1963 n=413 ??entry + outcome criteria; exclusions from analysis Mawson 1967 n=404 ?outcomes Roydhouse 1970 n=426 - allocation, observer and recall bias Paradise 1984 n= 91, more severely affected ( 7 in 1 y 5 in 2y) small effect Paradise less affected (2 - 6 in 1y, 2-4 in 2y) pub’d eventually in 2002 – even smaller effect Cochrane review Burton 2007 ; Blakley 2009 OHNS– systematic review; Schilder 2004 BMJ Conclusion – tonsillectomy works a wee bit. 1998 International Paed T’s rate per 10,000 population (Akker, 2004) Canada Scotland USA Australia N Ireland 0 20 40 60 80 100 120 140 15 year fall in rates of UK ENT surgery 80000 70000 60000 50000 Adenoids Grommets Tonsils 40000 30000 20000 10000 0 Mid 1990s 2008 - 09 UK Tonsil Admissions 40000 1990-00 35000 2008-09 30000 25000 20000 15000 10000 5000 0 Child Op Child Emergency NHS Tonsil Ops <15years old per 100,000 population Suleman Clin Otolaryngol 2010 800 700 600 500 400 300 200 100 0 Barrow Tameside Calderdale / Luton Oldham Walsall Manchester Kensington Harrow Rushcliffe 729 eligible; 268 randomised NESSTAC Arch Dis Child 2010 70 Medical 60 RCT 50 40 Surgery 30 20 10 0 n sore throats % Mean days % School Persistent off school progress s/t down ITT comparison of the NESSTAC randomised arms. Tonsillectomy: fewer episodes of sore throat Relative Risk Year 1 = 0.74; Year 2 = 0.51 The estimated Intention to Treat effect of tonsillectomy in randomised patients = 3.5 fewer sore throat episodes in two years Incremental cost-effectiveness ratio of £261 per sore throat avoided. % Switch rates – 36% overall 30 25 20 15 10 5 0 RCT Med RCT Surg Cohort Med Cohort surg The “average” child Episodes of sore throat saved 9 8.7 8.4 Year 1 8.1 8 7.1 7 6 n Year 2 Total 5 4 3 2 1 0 1 2 3 6 Months delay As treated analysis As-treated analysis = > 8 sore throats saved in 2 years if operation is performed <10 weeks of consultation = £154 per sore throat avoided. Quality of Life T14 –Hopkins et al JLO 2010 – effect size = 1.53 PedsQL – NESSTAC – similar physical health at 24 months –surgical preference group worse at baseline (HTA Journal 2010; 14, No. 13 ) OHNS Supplement 2008. – Goldstein - improvements general and disease specific tools Lock J of Child Health Care 2010 – emphasises the family QoL impact NESSTAC Conclusions Tonsillectomy significant clinical effect in reducing sore throats, at a reasonable cost. The effect depends on timing of surgery, as the health of all children with recurrent sore throat improves over time. Qualifying children should be treated promptly, as early intervention = maximum benefit. This is important if there is a high social or educational impact. Early intervention – cost £154 per sore throat saved More baseline data would have informed the analysis Core problem of surgical trials “Intention To Treat” RCT analysis But worst cases tend to switch from the nontreatment arm into treatment Surgery is irreversible: issues of acceptability; design ( no cross over) Net result = modest effect = easily dismissed as “Expectancy bias”. i.e. surgical placebo component (essentially uncontrolled for) No shift in surgical criteria or perception of effectiveness Willingness to pay Burton – “how much uncertainly are HC providers willing to fund?” How much were NESSTAC parents willing to pay for tonsillectomy? – Mean = £8000 – Median = £5000 http://www.hta.ac.uk/pdfexecs/summ1413.pdf Clinicians who perform tonsillectomy should determine their rate of primary and secondary post tonsillectomy haemorrhage at least annually Watson Newcastle upon Tyne 1993 N=1036 Monopolar diathermy faster than ties No difference 2° bleeds Study powered e.g. to detect difference 3% versus 7% secondary haemorrhage Bipolar Diathermy dissection 1994: Descriptive; 4 ml blood loss. 2° haemorrhage = 3% 1995: randomised n=120 BP faster (11min) and less blood loss (5 ml) 2° Haemorrhage – 3.4% cold (2 pts) vs. 1.7 % BP diathermy Needed ~ 3000 pts to achieve significance BP versus Cold in Portugal Silveira 2003 N=60; alternating allocation Needed 34% bleed in one group for significance BP vs Cold Turkey Kazali 2005 N=40, randomised BP faster (14min) and less blood loss (14 ml) 2° Haemorrhage – Nil… Powered to detect 0% versus 38% UK Audit (2005) n=33,900 www.rcseng.ac.uk 90% power to detect significant differences with p<0.01…… 3.9% readmission OR haemorrhage BP diathermy = 2.47 BP haemostasis not dissection = 1.57 Laryngoscope 2010 Tomkinson et al Welsh Data 2003-08 N=17480 All techniques using heat had a sig. increase in secondary haemorrhage Odds of Secondary Haemorrhage 14 12 10 8 6 4 2 0 Cold D Diss +BP+tie Diss+BP Coblation Cobl+BP or ties What IS the bleeding rate?! Secondary bleeds…. Takwoingi 2007 JLO UK 8-9% Attner 2009 Sweden - Karolinska - 5.5% Gi 2010 Netherlands – Guillotine 0.28% Kim 2010 Korea 3% children; 10% adults Mortality – recent data German Surveillance unit for rare paed disorders – 2 deaths in 2 years – Bidlingmaier 2010 32 deaths identified in literature Windfuhr 2009 Suggest about one per annum in UK? Most deaths due to airway obstruction Clot is hard to get out MUST have capacity for rigid bronchoscopy – STAT - plus or minus trache Surgical Standards (Narula et al Clin Otol 2011) “% surgeons operating on children who are trained in Paediatric Basic Life Support” 46% 3 hospitals only met one standard Sore throat Take Home messages We need more baseline data about ALL sore throats, and their response to surgery. ? BAPO can set up a national primary / secondary care interface sore throat pathway (better than waiting at the ‘end of the line’ to offer an operation) We have reached the limits of RCTs Most bleed rate studies = massively underpowered Secondary haemorrhage is sig > with ‘hot’ techniques and proportional to the amount of ‘heat’ used, peaking with Coblation plus other methods. What will it take to convince ENT surgeons if audits of tens of thousands of patients fail? UK has ~ one tonsillectomy death per year Resuscitation skills seem woefully maintained – at least in London – time for urgent remedial action! Considerations in T+A for OSA Selection OSA cure rate Other outcomes – – Behaviour – Neuro-cognition – Quality of life Risk Sources AAO HNS Guidelines Roland OHNS 2011 BMJ Clinical Review Powell 2010 UK working party Robb 2009 Meta-analysis in obese children Costa OHNS 2009 Beyond tonsillectomy Praud 2008 Review – Behavior, neurocognition and quality of life – Mitchell IJPO 2006 ? WHO ? 25% fail – at least Sleep study – – diagnosis – Severity – Central apnoea – Risk of complication (high AHI –Ye, J of OHNS 2009) ? No brainer? – get a sleep study ….or – perhaps not bother AAOHNS – sleep study if co morbidity or if need for surgery is ‘uncertain’ – Admit for monitoring if severe i.e. AHI> 10 /hour or SaO2 <80% UK Position – “the normal child with severe OSA is also at risk of perioperative problems but is … difficult to identify” – “children with severe OSA should be referred for further investigation” – “it is well recognised that a proportion of children with severe OSA are acutely sensitive to ..anaesthetic agents” BMJ 2010 – “Polysomnography is the optimal investigation” – “It is not logistically possible for all snoring children to have polysomnography” RCPCH management guideline – “reliable discrimination of snoring and OSA requires polysomnography” Consider Beyond tonsillectomy Praud 2008 Orthodontic features of OSA – LofstrandTidstrom; Souki both 2010 IJPO What about BMI? How do YOU assess child’s weight / BMI in OPD? Cochrane Natural Hx not fully delineated “The quality of research in this area could be improved by the use of sleep studies at baseline” Review – Behavior, neurocognition and quality of life – Mitchell IJPO 2006 – same conclusion. More investigation BASELINE evidence is missing – as it was in NESSTAC Challenges for BAPO? Mandate for up to date resuscitation skills across the board Better understanding of the natural history – Primary and secondary care work– capture the sore throat ‘prequel’ in real time. – T14 review of ALL subjects not just the operative cases - More willingness to pay work Better handle on emergencies For OSA: work towards use of pre and post operative ; better risk assessment OSA-18 and sleep testing
Similar documents
Global Cold, Cough and Sore Throat Remedies Market
Common cold, cough and sore throat are minor disorders of respiratory system, usually arises due to infection in respiratory tract and autoimmune response. The number of patients suffering from cold, cough and sore throat usually increases during monsoon and winter season, owing to fluctuations in the environmental conditions. Children and women under 35 years are more prone to suffer from cold, cough and sore. Underdeveloped immune system increases the risk of exposure to cold related infection viruses in children mostly. It is expected that children are three times more susceptible to cold and cough than an average adult.
More information